← SynDRA
METHOXSALEN
SynDRA canonical compound SYN0000077 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP3A4 |
|---|
| Mechanism of action | DNA synthesis inhibitor |
|---|
| Indication | psoriasis |
|---|
| Disease area | dermatology |
|---|
All known targets
- CYP1A2
- CYP2A6
- ACHE
- CYP1A1
- CYP2A13
- CYP3A4
- TAS2R20
- MAOA
- PPO2
Mechanisms of action (all sources)
- DNA synthesis inhibitor
- TAS2R20 AGONIST
- CYP2A6 BINDER
Drug classes
- Photoabsorption
- Cross-Linking Reagents
- Dermatologic Agents
- Indicators and Reagents
- Photosensitizing Agents
- Radiation-Sensitizing Agents
- Psoralen
- Photoactivated Radical Generator
ATC classes
- D05B · ANTIPSORIATICS FOR SYSTEMIC USE
- D05A · ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- 8-MOP
- methoxsalene
- 8-Methoxypsoralen
- 8-Methoxypsoralene
- deltapsoralen
- meladinin
- meladinine
- meladoxen
- meloxine
- oxsoralen
- xanthotoxin
- xanthotoxine
- 8-methoxsalen
- Metoxalen
- Oxypsoralen
- Puvalen
- Vitpso
- METHOXSALEN COMPONENT OF SM-88
- NSC-45923
- 8-mop
- Deltasoralen
- Meladinine
- Oxsoralen
- Oxsoralen-ultra
- Puvasoralen-8
- Uvadex
- Ammodin
- Ammoidin
- Dermox
- Geroxalen
- Meladinin
- Meladinina
- Meladoxen
- Meloxine
- Methoxalen
- Methoxaten
- Oxoralen
- Puvamet
Reported adverse events
Look up METHOXSALEN in the interactive SynDRA portal →